Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DocMorris AG (DOCM)
DocMorris AG stock price live, this page displays SIX DOCM stock exchange data. View the DOCM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DocMorris AG real time stock price chart below.
What Is the DocMorris AG Stock Price Today?
The DocMorris AG stock price today is 7.89.
What Is the Stock Symbol for DocMorris AG?
The stock symbol for DocMorris AG is ""DOCM.""
What Stock Exchange Does DocMorris AG Trade On?
DocMorris AG is listed and trades on the Switzerland stock exchange.
Is DocMorris AG a Good Stock to Buy?
Determining whether DocMorris AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DOCM quote. (ISIN: CH0042615283)
What Is the DocMorris AG Stock Price Today?
The DocMorris AG stock price today is 7.89.
What Is the Stock Symbol for DocMorris AG?
The stock symbol for DocMorris AG is ""DOCM.""
What Stock Exchange Does DocMorris AG Trade On?
DocMorris AG is listed and trades on the Switzerland stock exchange.
Is DocMorris AG a Good Stock to Buy?
Determining whether DocMorris AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DOCM quote. (ISIN: CH0042615283)
Switzerland
Currency in CHF
7.89
+0.07(+0.90%)
Delayed Data·
Fair Value
An estimate of a DocMorris's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.80
7.98
52 wk Range
6.21
50.85
DOCM Scorecard
Full Analysis
Operates with a significant debt burden
DOCM is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a DocMorris's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.807.98
52 wk Range
6.2150.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DOCM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a DocMorris's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
14.48
Upside
+83.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
May have trouble making interest payments on debt
- DocMorris AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Zur Rose receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
DocMorris AG Company Profile
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
DocMorris AG Earnings Call Summary for Q1/2025
- Q1 2025 revenue up 13% YoY; Rx revenue grew 52%, teleclinic services over 100%; stock surged 14.36% post-earnings
- 2025 outlook: 10%+ revenue growth expected; EBITDA guidance -€35M to -€55M; mid-term goal of 20% revenue CAGR and EBITDA breakeven by 2026
- CEO emphasized strategy of sustainable, self-funded growth; confident in achieving 10% online prescription penetration
- Challenges include competitive pressure, early market adoption in German digital health, and potential regulatory changes
- Q2 started strong with continued Rx growth; optimism about German coalition agreement's support for digital health services
Last Updated: 10/04/2025, 11:00
Read Full TranscriptCompare DOCM to Peers and Sector
Metrics to compare | DOCM | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipDOCMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.3x | 23.9x | 12.2x | |
PEG Ratio | 0.00 | 0.26 | 0.03 | |
Price/Book | 1.2x | 2.6x | 1.5x | |
Price / LTM Sales | 0.4x | 0.3x | 0.9x | |
Upside (Analyst Target) | 65.0% | 31.1% | 17.3% | |
Fair Value Upside | Unlock | 6.6% | 11.0% | Unlock |
Analyst Ratings
4 Buy
5 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 14.48
(+83.52% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-2.13 / --
Revenue / Forecast
280.64M / 273.10M
People Also Watch
FAQ
What Stock Exchange Does DocMorris Trade On?
DocMorris is listed and trades on the Switzerland Stock Exchange stock exchange.
What Is the Stock Symbol for DocMorris?
The stock symbol for DocMorris is "DOCM."
What Is the DocMorris Market Cap?
As of today, DocMorris market cap is 376.31M.
What Is DocMorris's Earnings Per Share (TTM)?
The DocMorris EPS (TTM) is -9.63.
When Is the Next DocMorris Earnings Date?
DocMorris will release its next earnings report on 15 Oct 2025.
From a Technical Analysis Perspective, Is DOCM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has DocMorris Stock Split?
DocMorris has split 2 times.
How Many Employees Does DocMorris Have?
DocMorris has 1454 employees.
What is the current trading status of DocMorris (DOCM)?
As of 30 Jul 2025, DocMorris (DOCM) is trading at a price of 7.89, with a previous close of 7.82. The stock has fluctuated within a day range of 7.80 to 7.98, while its 52-week range spans from 6.21 to 50.85.
What Is DocMorris (DOCM) Price Target According to Analysts?
The average 12-month price target for DocMorris is CHF14.48, with a high estimate of CHF35 and a low estimate of CHF8. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +83.52% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.